Abstract
There is limited data assessing length of stay, cost of care, and differences in demographic data in hospitalized psoriasis patients with and without cardiovascular disease. Our study compares hospitalized psoriatic patients with and without comorbid cardiovascular disease for differences in length of stay and cost of care, as well as to assess differences in patient demographics. A cross-sectional study of hospital encounters of patients under the age of 60 with psoriasis in the National Inpatient Sample from 2016 to 2020 was performed using univariate analyses and a multivariable logistic regression model. A total of 2,485 psoriasis hospitalizations were included. 2,145 (86.3%) had psoriasis without cardiovascular disease and 340 (13.7%) had psoriasis with cardiovascular disease. Linear regression models identified significantly longer lengths of stay (Beta: 1.6; SE: 0.721; P = 0.030) and higher cost of care (Beta: 4,946; SE: 1,920; P = 0.011) in psoriasis patients with cardiovascular comorbidities.
Data availability
Our study utilizes a publicly available data source containing de-identified information.
Code availability
Not applicable.
References
**dal S, **dal N (2018) Psoriasis and Cardiovascular diseases: a Literature Review to determine the causal relationship. Cureus 10(2):e2195
Liu L, Cui S, Liu M, Huo X, Zhang G, Wang N (2022) Psoriasis increased the risk of adverse Cardiovascular outcomes: a new systematic review and Meta-analysis of Cohort Study. Front Cardiovasc Med 9:829709
Garshick MS, Ward NL, Krueger JG, Berger JS (2021) Cardiovascular risk in patients with psoriasis: JACC review topic of the week. J Am Coll Cardiol 77(13):1670–1680
Hu SCS, Lan CCE (2017) Psoriasis and Cardiovascular comorbidities: focusing on severe vascular events, Cardiovascular Risk factors and implications for treatment. Int J Mol Sci 18(10). https://doi.org/10.3390/ijms18102211
HCUP National Inpatient Sample (NIS) Healthcare Cost and Utilization Project (HCUP). Published online 2016–2020
R Core Team. R: A Language and Environment for Statistical Computing (2022) https://www.r-project.org/
Ryan C, Kirby B (2015) Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin 33(1):41–55
von Stebut E, Boehncke WH, Ghoreschi K et al (2019) IL-17A in Psoriasis and Beyond: Cardiovascular and metabolic implications. Front Immunol 10:3096
Acknowledgements
Not applicable.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
All authors contributed equally to the conception, the drafting, and the critical revision of the manuscript. SP prepared the tables. All authors read and approved the final version.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Conflict of interest
DGE, FJE, SP, AH, LH, and KN declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Eckembrecher, D.G., Eckembrecher, F.J., Patel, S. et al. A cross-sectional study of psoriasis hospitalizations in patients with cardiovascular comorbidities in patients under 60. Arch Dermatol Res 316, 322 (2024). https://doi.org/10.1007/s00403-024-02999-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00403-024-02999-x